Med-El, Advanced Bionics Launch Behind-the-Ear Speech Processors
This article was originally published in The Gray Sheet
Executive Summary
Med-El is touting the extended battery life of its Combi 40+ cochlear implant system as a major competitive advantage following its recent U.S. launch of the product.
You may also be interested in...
Advanced Bionics Defers Current Profits To Stimulate Neurostimulation
Advanced Bionics is investing in implantable neurostimulators to extend beyond its initial product segment in cochlear implants. The Sylmar, California company is predicting the start of clinical trials on neurostimulators for urge incontinence and pain by the end of this year
Advanced Bionics Defers Current Profits To Stimulate Neurostimulation
Advanced Bionics is investing in implantable neurostimulators to extend beyond its initial product segment in cochlear implants. The Sylmar, California company is predicting the start of clinical trials on neurostimulators for urge incontinence and pain by the end of this year
Advanced Bionics' Bionic Ear Marketing Claims Out Of Tune, FDA Says
Advanced Bionics maintains that it has FDA approval to market its CII Bionic Ear cochlear implant in the U.S., despite receiving a Sept. 24 warning letter from the Center for Devices and Radiological Health.